Publications (225) Publications de PABLO LUIS ORTIZ ROMERO

filter_list

2025

  1. Comparative effect of metformin and SGLT2i on vascular risk and mortality in hidradenitis suppurativa

    Journal of the European Academy of Dermatology and Venereology

  2. Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

    Journal of the European Academy of Dermatology and Venereology

  3. Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

    Journal of the European Academy of Dermatology and Venereology, Vol. 39, Núm. 4, pp. 833-845

  4. Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterization

    Journal of the European Academy of Dermatology and Venereology

  5. Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT”

    European Journal of Cancer, Vol. 222

  6. Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members

    International Journal of Radiation Oncology Biology Physics, Vol. 121, Núm. 4, pp. 1006-1010

  7. Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study

    Cancers, Vol. 17, Núm. 7

  8. Skin lesions after hematopoietic stem cell transplantation: Graft-versus-host disease versus true dermatomyositis

    JDDG - Journal of the German Society of Dermatology

  9. Skin lesions after hematopoietic stem cell transplantation: Graft-versus-host disease versus true dermatomyositis

    JDDG - Journal of the German Society of Dermatology

2024

  1. Approach to Mycosis Fungoides in children: Consensus-based recommendations

    Journal of the American Academy of Dermatology, Vol. 91, Núm. 6, pp. 1078-1085

  2. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

  3. Hair repigmentation in Sézary syndrome

    Journal of the European Academy of Dermatology and Venereology

  4. Intralesional brentuximab vedotin for the treatment of primary cutaneous T-cell lymphomas: a case series

    International Journal of Dermatology

  5. Maintenance therapy for CTCL: importance for prevention of disease progression

    Leukemia and Lymphoma, Vol. 65, Núm. 12, pp. 1883-1890

  6. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases

    Journal of the European Academy of Dermatology and Venereology

2023

  1. A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

    Cancers, Vol. 15, Núm. 23

  2. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  3. Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion (American Journal of Clinical Dermatology, (2023), 24, 1, (5-14), 10.1007/s40257-022-00732-w)

    American Journal of Clinical Dermatology

  4. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

    Actas Dermo-Sifiliograficas

  5. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

    European Journal of Cancer, Vol. 195